Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional study

Z Z N Yiu¹, G Harding-Oredugba², C E M Griffiths¹, R B Warren¹, E McMullen¹, H J A Hunter¹

Affiliations

¹ Centre for Dermatology Research, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester, UK.
² Business Information Department, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

PMID: 33730411
PMCID: PMC8250602
DOI: 10.1111/bjd.20062

Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional study

Z Z N Yiu et al. Br J Dermatol. 2021 Aug.

. 2021 Aug;185(2):441-443.

doi: 10.1111/bjd.20062. Epub 2021 May 31.

Authors

Z Z N Yiu¹, G Harding-Oredugba², C E M Griffiths¹, R B Warren¹, E McMullen¹, H J A Hunter¹

Affiliations

¹ Centre for Dermatology Research, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester, UK.
² Business Information Department, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

PMID: 33730411
PMCID: PMC8250602
DOI: 10.1111/bjd.20062

No abstract available

PubMed Disclaimer

Cited by

Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics.
Graceffa D, Sperati F, Bonifati C, Spoletini G, Lora V, Pimpinelli F, Pontone M, Pellini R, Di Bella O, Morrone A, Cristaudo A. Graceffa D, et al. Front Med (Lausanne). 2022 Sep 6;9:961904. doi: 10.3389/fmed.2022.961904. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36148445 Free PMC article.
Clinical Dermatology and COVID-19 Pandemic: Narrative Review.
Mintoff D, Chatterjee M, Podder I, Shipman A, Das A. Mintoff D, et al. Indian J Dermatol. 2021 May-Jun;66(3):246-255. doi: 10.4103/ijd.ijd_463_21. Indian J Dermatol. 2021. PMID: 34446947 Free PMC article.
Impact of COVID-19 pandemic on adults and children with atopic dermatitis and food allergy: Systematic review.
Ne CKH, Suaini NHA, Aung WT, Ong KGS, Samuel M, Tham EH. Ne CKH, et al. J Allergy Clin Immunol Glob. 2023 Oct 18;3(1):100181. doi: 10.1016/j.jacig.2023.100181. eCollection 2024 Feb. J Allergy Clin Immunol Glob. 2023. PMID: 38026506 Free PMC article.
Vaccination, Risk Factors and Outcomes of COVID-19 Infection in Patients with Psoriasis-A Single Centre Real-Life Experience from Eastern Slovakia.
Baloghová J, Kampe T, Kolarčik P, Hatalová E. Baloghová J, et al. Viruses. 2022 Jul 27;14(8):1646. doi: 10.3390/v14081646. Viruses. 2022. PMID: 36016267 Free PMC article.
Biologics for Psoriasis During the COVID-19 Pandemic.
Zeng H, Wang S, Chen L, Shen Z. Zeng H, et al. Front Med (Lausanne). 2021 Dec 6;8:759568. doi: 10.3389/fmed.2021.759568. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34938746 Free PMC article. Review.

See all "Cited by" articles

References

1. Williamson EJ, Walker AJ, Bhaskaran K et al. Factors associated with COVID‐19‐related death using OpenSAFELY. Nature 2020; 584:430–6. - PMC - PubMed
1. Keswani A, Dhana K, Rosenthal JA et al. Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019. Ann Allergy Asthma Immunol 2020; 125:479–81. - PMC - PubMed
1. Gelfand JM, Armstrong AW, Bell S et al. National Psoriasis Foundation COVID‐19 Task Force guidance for management of psoriatic disease during the pandemic: version 2 ‐ advances in psoriatic disease management, COVID‐19 vaccines, and COVID‐19 treatments. J Am Acad Dermatol 2021; 84:1254–68. - PMC - PubMed
1. Khan SS, Marshall CL, Stylianou KA et al. An evaluation of dermatology patients shielding during the COVID‐19 outbreak. Clin Exp Dermatol 2021; 46:193–4. - PMC - PubMed
1. Mahil SK, Yates M, Langan SM et al. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey. Br J Dermatol 2020; 10.1111/bjd.19755. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional study

Affiliations

Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional study

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical